- Home
- FGI vs PMCB Comparison
FGI vs PMCB Comparison
Compare FGI & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGI
- PMCB
- Stock Information
- Founded
- FGI 1987
- PMCB 1996
- Country
- FGI United States
- PMCB United States
- Employees
- FGI N/A
- PMCB N/A
- Industry
- FGI Industrial Specialties
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FGI Industrials
- PMCB Health Care
- Exchange
- FGI Nasdaq
- PMCB Nasdaq
- Market Cap
- FGI 6.8M
- PMCB 5.8M
- IPO Year
- FGI 2022
- PMCB N/A
- Fundamental
- Price
- FGI $3.63
- PMCB $0.90
- Analyst Decision
- FGI
- PMCB
- Analyst Count
- FGI 0
- PMCB 0
- Target Price
- FGI N/A
- PMCB N/A
- AVG Volume (30 Days)
- FGI 59.1K
- PMCB 38.8K
- Earning Date
- FGI 08-11-2025
- PMCB 08-11-2025
- Dividend Yield
- FGI N/A
- PMCB N/A
- EPS Growth
- FGI N/A
- PMCB N/A
- EPS
- FGI N/A
- PMCB 3.19
- Revenue
- FGI $135,904,413.00
- PMCB N/A
- Revenue This Year
- FGI $7.72
- PMCB N/A
- Revenue Next Year
- FGI $6.94
- PMCB N/A
- P/E Ratio
- FGI N/A
- PMCB $0.28
- Revenue Growth
- FGI 12.30
- PMCB N/A
- 52 Week Low
- FGI $2.28
- PMCB $0.80
- 52 Week High
- FGI $5.50
- PMCB $2.42
- Technical
- Relative Strength Index (RSI)
- FGI 47.51
- PMCB 41.85
- Support Level
- FGI $3.26
- PMCB $0.84
- Resistance Level
- FGI $3.87
- PMCB $0.95
- Average True Range (ATR)
- FGI 0.56
- PMCB 0.07
- MACD
- FGI -0.07
- PMCB -0.00
- Stochastic Oscillator
- FGI 22.70
- PMCB 39.96
About FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.